| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Arcutis Biotherapeutics, Inc. | Chief Commercial Officer | Common Stock | 63,429 | $224,589 | $3.54 | 06 Mar 2023 | Direct |
| Arcutis Biotherapeutics, Inc. | Chief Commercial Officer | Stock Option (Right to Buy) | 55,800 | 02 Mar 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ARQT | Arcutis Biotherapeutics, Inc. | 06 Mar 2023 | 1 | -$12,684 | 4 | Chief Commercial Officer | 08 Mar 2023, 15:25 |
| ARQT | Arcutis Biotherapeutics, Inc. | 02 Mar 2023 | 2 | $0 | 4 | Chief Commercial Officer | 06 Mar 2023, 17:57 |
| ARQT | Arcutis Biotherapeutics, Inc. | 28 Feb 2023 | 3 | -$37,796 | 4 | Chief Commercial Officer | 02 Mar 2023, 18:04 |
| ARQT | Arcutis Biotherapeutics, Inc. | 03 Mar 2022 | 4 | -$17,234 | 4 | Chief Commercial Officer | 07 Mar 2022, 19:49 |
| ARQT | Arcutis Biotherapeutics, Inc. | 01 Mar 2022 | 1 | -$16,599 | 4 | Chief Commercial Officer | 03 Mar 2022, 15:15 |